SNL Sketch Exposes the Absurd Disconnect of Online Realities
A recent SNL sketch skillfully highlights how personalized algorithms can distort our perceptions and connections in real life.
October 04, 2026
Technology
Latest technology news and innovations
NIH Unveils Revamped Website for Enhanced Access to Health Research Information
The NIH is launching a new website design focused on core themes to simplify public access to health and biomedical research information.
October 02, 2026
Lilly's Direct-to-Consumer Strategy Avoids Australian Pharmacies
Lilly adopts a direct-to-consumer model in Australia, bypassing traditional pharmacies to streamline access to its products.
October 02, 2026
NIH Faces Criticism Over Grant Distribution and Delays in Research Funding
NIH's fiscal year 2026 grant distribution raises concerns among researchers due to delays and a decline in project funding.
October 02, 2026
Pharmacy Perspectives: Bridging the Gap Between Orphan Drugs and Patient Needs
Pharmacists face challenges in the orphan drug landscape, as policy gaps hinder personalized care for patients with specific conditions.
October 02, 2026
Assessing Medical Preparedness for Extreme Heat at Marathons
A firsthand account of heat-related incidents at the NYC Marathon highlights the urgent need for better medical planning in response to climate change.
October 02, 2026
China's Biotech Growth: Insights from an On-the-Ground Perspective
Explore the vibrant pulse of China's biotech sector, offering firsthand insights into its rapid advancements and ongoing challenges.
October 01, 2026
Blue Shield of California Plans to Implement Medicare-Inspired Payment Models by 2027
Blue Shield of California aims to adopt Medicare-inspired payment models, enhancing care for six million members by 2027.
October 01, 2026
New Medicare Drug Pricing Rule and Eli Lilly's Weight Loss Drug Show Promise
The Trump administration's latest Medicare drug pricing rule falls short, while Eli Lilly's combination therapy shows significant weight loss results.
October 01, 2026
Invivyd's Monoclonal Antibody Shows Promising Results Against Covid-19
Invivyd's Phase 3 study shows its monoclonal antibody, VYD2311, offers better tolerability than the Pfizer vaccine, suggesting a potential alternative for Covid-19 protection.
October 01, 2026
Huntington's Advocate Responds to UniQure's Latest Gene Therapy Results
Despite a decline in effectiveness, Huntington's patient Lauren Holder remains optimistic about UniQure's gene therapy for slowing disease progression.
October 01, 2026
China's Biotech Sector Champions Efficiency Amid Global Competition
Biotech leaders in Shanghai tout rapid drug development in China, positioning themselves as a competitive force against Western markets.
October 01, 2026
Study Reveals Lingering Health Risks from Toxic Metals Post-Wildfires in Maui
Research highlights the long-term respiratory risks posed by toxic metals from the 2023 Maui wildfires, persisting even after the flames have subsided.
September 28, 2026
Merck Halts U.S. Supply of Recarbrio Amid Antibiotic Resistance Concerns
Merck's recent decision to discontinue Recarbrio raises questions about the pharmaceutical industry's commitment to tackling antibiotic resistance.
September 28, 2026
AbbVie Gains FDA Approval for New Parkinson's Treatment Pill
The FDA has approved AbbVie's new oral medication for Parkinson's disease, marking a significant advancement in treatment options for patients.
September 28, 2026
Shifting Strategies: GLP-1s Marketed as Lifestyle Enhancements Amid Setbacks for Merck and Daiichi
GLP-1 drugs are now being marketed for general wellness rather than just obesity, while Merck and Daiichi face setbacks in cancer therapy approval.
September 28, 2026
GLP-1 Drugs Transition from Medical Solutions to Lifestyle Enhancements
GLP-1 medications are shifting focus from medical obesity treatments to lifestyle products, reflecting a broader marketing strategy by companies like Novo Nordisk.
September 28, 2026
AI's Dual-Use Dilemma: The Fine Line Between Medical Research and Bioweapons
Recent cases reveal how AI technology can unintentionally facilitate bioweapons development, blurring the lines of scientific intent.
September 28, 2026
Uncovering New Insights in Cardiac Anatomy Through Observation
A recent discovery in the anatomy of the heart challenges established knowledge, revealing a previously unrecognized structure and its implications for stroke risk.
September 28, 2026
Eleven Manufacturers Secure Generic Licensing for Roche's Influenza Treatment
A U.N.-backed agency has partnered with 11 manufacturers to produce generic versions of Roche's flu treatment Xofluza, enhancing access in low-income nations.
September 25, 2026